Organon Total Liabilities 2019-2025 | OGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Organon total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Organon total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$148.1B
CVS Health (CVS)	$75.9B
Elevance Health (ELV)	$65B
Cencora (COR)	$56.2B
DiDi Global (DIDIY)	$25.7B
Labcorp Holdings (LH)	$21.9B
Natera (NTRA)	$18.5B
BioMerieux (BMXMF)	$17.1B
EUROFINS SCIENT (ERFSF)	$15.2B
ICON (ICLR)	$15B
CochLear (CHEOY)	$13.6B
Solventum (SOLV)	$12.7B
Medpace Holdings (MEDP)	$12.6B
Revvity (RVTY)	$11.1B
Viatris (VTRS)	$10.8B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.1B
Charles River Laboratories (CRL)	$8.8B
HealthEquity (HQY)	$8.3B
Caris Life Sciences,�Inc (CAI)	$7B
Bausch + Lomb (BLCO)	$5.2B
Amplifon S.p.A (AMFPF)	$5.1B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.4B
Surgery Partners (SGRY)	$2.9B
GeneDx Holdings (WGS)	$2.6B
Concentras Parent (CON)	$2.6B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B
PACS (PACS)	$1.8B